2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z

Lack of Specificity of LC-MS/MS Based Urinary Biomarkers for Polyomavirus BK Nephropathy (BKPyVN).

G. Zeng,¹ L. Pan,² Z. Lyu,² Y. Huang,¹ P. Randhawa.¹
Lack of Utility of KDPI in Dual Kidneys from Donors at the Extremes of Age.

D. Felts, M. Khan, B. Alradawna, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, A. Palanisamy, W. Doares, S. Kaczmorski, R. Stratta.
Lack of Xenograft Recipient Monitoring by Telemetry Lets Infection Go Unchecked and Trigger Coagulopathy.

M. Mohiuddin,¹ A. Singh,¹ J. Chan,¹ P. Corcoran,¹ B. Lewis,² M. Thomas,² D. Ayares,³ K. Horvath.¹
Lactate Level Immediate Post-Liver Transplantation Is a Predictor of Early Allograft Dysfunction.

K. Takahashi,^1,2 S. Nagai,¹ M. Safwan,¹ K. Putchakayala,¹ K. Collins,¹ M. Rizzari,¹ A. Yoshida,¹ M. Abouljoud,¹ S.-M. Jafri.³
Landscape of Multiple Donations from a Living Donor in the US.

A. Thomas,¹ A. Massie,¹ J. Garonzik-Wang,¹ K. Lentine,² M. Henderson,¹ D. Segev.¹
Laparoscopic Sleeve Gastrectomy Improves Renal Transplant Candidacy and Posttransplant Outcomes in Morbidly Obese Patients.

Y. Kim, A. Jung, V. Dhar, J. Tadros, R. Alloway, A. Shields, S. Woodle, T. Diwan.
Largest US Series of Minimally Invasive Full and Laparoscopy-Assisted Living Donor Hepatectomy.

K. Collins, J. Emond, A. Fox, B. Samstein.
Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.

T. Schachtner,^1,2 P. Reinke.^1,2
Lessons Learned from Simultaneous Biopsies of Both Kidney and Pancreas Grafts in Recipients of Simultaneous Kidney-Pancreas Transplants.

S. Parajuli, B. Astor, A. Djamali, R. Redfield, E. Arpali, D. Kaufman, J. Odorico, D. Mandelbrot.
Life Confocal Imaging of Murine Liver Biopsies as Novel Tool to Assess Graft Viability Prior to Transplantation.

R. Oberhuber, M. Fodor, B. Cardini, M. Maglione, M. Hermann, J. Troppmaier.
Life Threatening Disparities in Calculated MELD Due to Variation in Laboratory Methods within a UNOS Region.

E. Verna,¹ C. Connelly,¹ L. Dove,¹ J. Emond,¹ P. Adem,² N. Babic,³ J. Corsetti,⁴ J. Faix,⁵ J. Hayden,⁶ M. Lifshitz,⁷ M. Chiles,¹ S. Mohan,¹ H. Eldad,¹ A. Kratz.¹
Limited Impact of Pre-Existing Donor Specific HLA Antibodies on Long Term Survival After First Adult Liver Transplantation.

M. Koch,¹ M. Marget,² M. Sterneck,³ H. Thude,¹ B. Nashan.¹
Lipid Abnormalities and Cardiovascular Events After Early Conversion to Everolimus in Kidney Transplant Recipients with Pretransplant Diabetes: 24-Month Analysis from Elevate Study.

M. van der Giet,¹ J. de Fijter,¹ F. Oppenheimer,¹ G. Russ,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ H. Holdaas.¹
Lipid Catabolism Provides Alternative Energy Source and Compensates for Mitochondrial Dysfunction in Reperfused Rat Kidneys After Ischaemia.

H. Huang,^1,2 L. van Dullemen,³ M. Akhtar,¹ M. Lo Faro,^1,2 A. Dona,⁴ M. Kaisar,^1,2 H. Leuvenink,³ B. Kessler,² R. Ploeg.¹
Live Donor (LDTx) HIV(+) Kidney Transplantation Improves Allograft Survival vs. Deceased Donor (CRD) Transplantation.

G. Malat, D. Lee, K. Ranganna, S. Talluri, L. Levin Mizrahi, M. Harhay, C. Culkin, S. Guy.
Live Donor Liver Transplantation Using Grafts with More Than Two Bile Ducts – Does It Affect Patient Outcome?

D. Kollmann, G. Sapisochin, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, A. Ganekar, D. Grant, M. Selzner, N. Goldaracena.
Liver Allograft Hepatitis and Graft Loss After Hepatitis C Clearance.

D. Bruno, S. Brown, S. Hanish, J. LaMattina, W. Hutson, S. Kottilil, W. Twadell, R. Barth.
Liver Mesenchymal Stem Cells Inhibit T Cell Alloresponses.

T. Taner, M. Gustafson, M. Hansen, A. Dietz, M. Stegall.
Liver Regeneration in Porcine Hepatectomy Model.

H. Chen, D. Joo, M. Shaheen, J. Yang, S. Nyberg.
Liver Retransplantation: The Largest Post MELD Single Center Experience.

F. Kaldas, I. Korayem, V. Agopian, T. Russell, S. Ebaid, A. Zarrinpar, H. Yersiz, D. Farmer, R. Busuttil.
Liver Targeted Expression of a Single Allogeneic MHC I Molecule Promotes Tolerance to Pancreatic Islet Allograft by Inducing Specific CD8+ Regulatory T Cells in Mice.

V. Le Guen,^1,2 J.-P. Judor,^1,2 V. Gauttier,^1,2 N. Ferry,³ J.-P. Soulillou,^1,2 S. Brouard,^1,2 S. Conchon.^1,2
Liver Transplant Recipients Undergoing Non-Transplant Surgeries and Everolimus Use as Primary Immunosuppressant- Busting the Myth of Wound Infection Due to mTOR Inhibitors.

S.-C. Hsu, A. Thorat, L.-B. Jeng, H.-R. Yang, P.-C. Li, C.-C. Yeh, T.-H. Chen, K.-S. Poon.
Liver Transplantation Beyond MELD 40.

J. Scalea, D. Bruno, S. Hanish, J. Lamattina, J. Alvarez-Casas, S. Malik, A. Cimeno, S. Bartlett, R. Barth.
Liver Transplantation for Adolescents with Biliary Atresia in the PELD/MELD Era: An Analysis of the UNOS Database.

J. Chu,^1,2 R. Annunziato,³ D. Reinoso,³ A. Ramaswami,² R. Arnon.^1,2
Liver Transplantation for Babies Weighing Less Than 10 kg.

A. Akdur,¹ G. Moray,¹ F. Ozcay,² A. Torgay,³ M. Haberal.¹
Liver Transplantation Outcomes Using Anti-Thymocyte Globulin Induction in Patients with Autoimmune Hepatitis.

S. LeCorchick, A. Sharma, I. Yakubu, C. Bhati, T. Reichman, L. Kang, M. Levy.
Liver Transplantation Tolerance Using Outbred Mice.

M. Morita,¹ C. Miller,² J. Fung,³ L. Lu,^1,2 S. Qian.^1,2
Liver Transplantation Using Pediatric versus Adult Donor Grafts in Adult Recipients.

Z. Guo, Y. Tang, X. He, G. Chen.
Living and Deceased Donor Uterus Transplantation – The 2-Arm Czech Uterus Transplant Trial: The First Year Report with Four Cases Done so Far.

J. Fronek,¹ R. Chmel,² L. Janousek,¹ M. Novackova,² J. Matecha,² M. Olausson.³
Living Donor Liver Transplantation for Alcoholic Liver Disease.

H. Braun, J. Dodge, J. Roberts, N. Ascher.
Living Kidney Donor Pharmaceutical Care Needs Identified Through Linked Transplant Registry and Pharmacy Claims Data.

K. Lentine,¹ S. Gustafson,² M. Schnitzler,¹ G. Hess,³ D. Segev,⁴ A. Garg,⁵ N. Lam,⁶ D. Axelrod,⁷ D. Brennan,⁸ H. Randall,¹ B. Kasiske.⁹
Living Kidney Donors: Battling High Attrition Rates During Evaluation Process.

J. Verbesey, A. Bacigalupo, A. Gilbert, A. Li, C. Zuttermeister, M. Grafals, J. Moore, B. Javaid, P. Abrams, S. Ghasemian, M. Cooper.
Living Kidney Transplant: The Influence of Intraoperative Hemodynamics on Delayed Graft Function.

R. Schutt,¹ J. Case,¹ B. Barrick,¹ A. Toll,² C. Marsh.¹
Long Term Outcomes of Adult Kidney Transplants from Small Single Pediatric Donors Are Equivalent to Standard Criteria Donors.

R. McMillan, K. Gray, T. Khader, A. Jabri, J. Kim, A. Watkins.
Long Wait Time Regions for Liver Transplantation for HCC Have a Higher Cumulative Incidence of Death.

R. Hogen, J. Dinorcia, M. Lo, B. Nguyen, Y. Genyk, L. Sher, K. Dhanireddy.
Long-Term Analysis of Combined Liver-Lung Transplant Outcomes at a Single-Center.

K. Freischlag,¹ B. Ezekian,² M. Mulvihill,² S. Knechtle.²
Long-Term Clinical Outcomes of Kidney Transplant Recipients with Body-Size Mismatch Between Recipient and Donor.

Y. Takada,¹ D. Iwami,¹ K. Hotta,¹ K. Kanagawa,² H. Higuchi,¹ T. Hirose,¹ H. Sasaki,¹ N. Shinohara.¹
Long-Term Consequences of Post-Donation Preeclampsia.

H. Ibrahim,¹ D. Berglund,¹ S. Jackson,² A. Matas.¹
Long-Term Drug-Free Survival of Tiny Cynomolgus Islet Allografts.

M. Koulmanda, V. Chipashivili, M. Duggan, T. Strom.
Long-Term Follow-Up of the Safety and Effects of Bariatric Surgery on Immunosuppression in Post-Transplant Patients.

A. Keidar,¹ R. Yemini,¹ I. Carmeli,¹ E. Nesher,² J. Vinkler,² E. Mor,² M. Bendavid.¹
Long-Term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology.

E. Lorenz, B. Smith, F. Cosio, N. Shah, P. Groehler, J. Verdick, W. Park, M. Stegall.
Long-Term Liver and Kidney Survival Following Combined Liver-Kidney Transplantation, with or without Preformed Donor-Specific Antibodies.

A. Del Bello,¹ O. Bestard,² J. Visentin,³ N. Congy-Jolivet,¹ L. Couzi,³ M. Neau-Cransac,³ F. Jambon,³ N. Kamar.¹
Long-Term Malignancy Risk in Kidney Transplant Recipients Treated with Cyclophosphamide Pre-Transplant for Native Glomerular Disease.

J. Mills,¹ M. Jorgenson,¹ J. Fose,¹ B. Astor,² S. Panzer.²
Long-Term Outcome of Antibody-Mediated Rejection Due to Pre-Existing vs. De Novo DSA in Kidney Allograft Recipients.

O. Aubert,¹ C. Lefaucheur,¹ S. Higgins,¹ L. Hidalgo,² J. Duong Van Huyen,¹ D. Viglietti,¹ X. Jouven,¹ D. Glotz,¹ P. Halloran,² A. Loupy.¹
Long-Term Outcomes After Liver Transplantation (tx) with Everolimus (EVR) and Mycophenolic Acid (MPA) in a Calcineurin Inhibitor-Free Regimen: The CERTITUDE Trial.

F. Saliba,¹ C. Duvoux,² S. Dharancy,³ J. Dumortier,⁴ Y. Calmus,⁵ F. Di Giambattista,⁶ F. Conti.⁵
Long-Term Outcomes Among Slow versus Delayed or Immediate Graft Function Kidney Transplant Recipients: A Single-Center Experience.

I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Long-Term Outcomes in HIV(+) Kidney Re-Tranpslant (ReTx) Recipients vs. Primary Transplant (PrimTx) Recipients.

G. Malat, S. Guy, K. Ranganna, D. Reich, G. Xiao, S. Talluri, M. Harhay, L. Levin Mizrahi, C. Culkin.
Long-Term Outcomes of Kidney Transplant Recipients with Primary Idiopathic Focal Segmental Glomerulosclerosis (FSGS).

D. Khadzhynov, F. Halleck, L. Lehner, E. Schrezenmeier, K. Budde, O. Staeck.
Long-Term Outcomes of Renal Function in Pediatric Living Related Intestinal Transplantation.

S. Garcia Aroz,¹ K. Czech,² L. Briar,² G. Testa,³ E. Benedetti,¹ E. John.²
Long-Term Pediatric Live-Donor Liver Transplantation Survivors: Patient and Allograft Outcomes.

N. Celik,¹ A. Ganoza,¹ G. Bond,¹ K. Soltys,¹ R. Sindhi,¹ P. McKiernan,³ A. Humar,² G. Mazariegos.¹
Long-Term Persistence of Anti-HLA Antibodies in Renal Trasplant Recipients: Risk Factors and Impact on Clinical Course.

I. Perez-Flores,¹ J. Santiago,² B. Rodriguez-Cubillo,¹ M. Moreno De La Higuera,¹ V. Lopez De La Manzanara,¹ J. Bautista-Cañas,¹ N. Calvo Romero,¹ A. Shabaka,¹ E. Urcelay,² A. Sanchez-Fructuoso.¹
Long-Term Preservation of Renal Function in Liver Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Delayed Initiation of Calcineurin Inhibitors.

I. Bajjoka, A. Yaldo, C. Crombez, K. Brown, M. Abouljoud.
Longer Anastomotic Time Leads to Delayed Graft Function.

M. Heer,^1,2 P. Trevillian,^1,2,3 A. Hibberd.^1,2,3
Longer Ischemic Time Is Associated with Late Graft Dysfunction in Pediatric Heart Transplant Recipients.

L. Schroeder,¹ S. Chowdhury,¹ A. Burnette,¹ H. Baker,¹ A. Savage,¹ A. Atz,¹ R. Butts.²
Longer Pre-Transplant Dialysis Exposure Is More Frequent in Living Donor Kidney Transplantation (LDTX) Involving Lower Income Donor and Recipients and Is Associated with an Increased Risk of LDTX Failure.

J. Gill, C. Rose, J. Lesage, Y. Joffres, J. Gill.
Longitudinal Study of Donor Specific Antibodies in a Pediatric Kidney Transplant Population; Response to Optimization of Anti-Proliferative Therapy.

A. Rounds, M. Moss, M. Bock, J. Goebel.
Loss of Bat3 Could Promote Transplant Tolerance by Regulating CD4 ⁺ T Cells Function.

G. Gu, H. Hang, Q. Xia.
Low Dose Valganciclovir for CMV Prophylaxis in the First Year of Kidney Transplantation.

P. Klem,¹ L. Al-Omar,² J. Cooper,² S. Davis,² J. Gralla,² D. Choe,¹ A. Wiseman.²
Low Incidence of Acute Rejection within the Six Months After Transplantation in HIV Recipients Treated with Raltegravir, the ANRS 153 Treve Trial.

M. Matignon,¹ A. Lahiani,⁹ J. Lelievre,² D. Desvaux,⁶ K. Abassi,⁹ A. Diallo,⁹ M. Peraldi,⁷ A. Taburet,⁴ J. Saillard,⁵ C. Delaugerre,³ L. Assoumou,⁹ P. Grimbert,¹ TREVE ANRS Study Group.⁵
Low Level Early Onset De Novo DSA's May Not Portend Early Graft Dysfunction in Kidney Transplant Recipients.

M. Abate, Y. Nigatu, B. Ryu, F. Darras, R. Jafrin, H. Suh, C. Estrada, E. Nord.
Low Level Light Laser Treatment Reduces Macrophage Retention and ROS Levels Following Tissue Injury.

A. Paredes,¹ D. Benavidez,¹ R. Patil,¹ B. Khalil,¹ M. Mitchell,¹ J. Cheng,¹ S. Mangos,² A. Bartholomew.¹
Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate Risk Renal Transplants: A Single Center Experience.

A. Baghban,¹ K. Belfield,² M. Azar,¹ E. Cohen,² M. Malinis.¹
Lower Incidence of DSA-Induced Chronic Antibody-Mediated Rejection in Abo-Incompatible Renal Transplantation.

M. Okada,¹ Y. Watarai,¹ K. Iwasaki,² K. Futamura,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
Lower Mean Tacrolimus Troughs Increase Risk of De Novo Donor-Specific Antibodies in the First Year of Kidney Transplant.

S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.
Lower Rates of Living Donation Among Transplant Centers Located in the Stroke Belt.

R. Reed, B. Shelton, P. MacLennan, M. Hanaway, V. Kumar, R. Gaston, J. Locke.
Lung Preservation Solution Exposure at Cardiac Procurement Is Associated Increased Incidence of Coronary Arterial Vasculopathy.

H. Copeland,¹ V. Garcia,² A. Sima,² D. Baran,³ A. Mankind,⁴ G. Katlaps,¹ N. Lewis,⁴ B. Dharmaj,¹ J. Copeland.⁵
Lung Transplant Recipient Travel Distance to Transplant Center Does Not Impact Survival.

W. Tsuang,¹ S. Lin,² J. Schold,² M. Valapour.¹
Lymph Node Stromal Laminins Differentially Regulate T Cell Activation.

T. Simon, J. Bromberg.
Lymphoid Isolation as an Adjuvant Maneuver for Belatacept-Based Immunotherapy.

M. Mulvihill,¹ K. Samy,² R. Davis,¹ F. Leopardi,¹ B. Collins,¹ A. Kirk.¹
Lymphoproliferative Disorders After Renal Transplantation Along Two Decades: A Large Longitudinal Study.

A. Franco,¹ D. Hernandez,² N. Maruri,³ A. Alonso,⁴ M. Crespo,⁵ A. Mazuecos,⁶ C. Diaz-Corte,⁷ M. Gentil.⁸
Lymphotoxin (LT) β Receptor-Mediated Non-Classical NFκB Signaling in Lymphatic Endothelial Eells (LEC) is Required for Homeostatic T Cell Migration.

W. Piao, C. Brinkman, J. Bromberg.

Jump to: View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z